MEDICINOVA INC (MNOV) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 95 transactions totaling $1.6M, demonstrating a bullish sentiment with $1.1M in net insider flow. The most recent transaction on Jan 16, 2026 involved a transaction of 350,000 shares valued at $0.
No significant insider buying has been recorded for MNOV in the recent period.
No significant insider selling has been recorded for MNOV in the recent period.
Based on recent SEC filings, insider sentiment for MNOV is bullish with an Insider Alignment Score of 84/100 and a net flow of $1.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at MEDICINOVA INC (MNOV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading MNOV stock, having executed 95 transactions in the past 90 days. The most active insider is Masatsune Okajima (Executive), who has made 15 transactions totaling $4.1M.
Get notified when executives and directors at MNOV file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | Matsuda Kazuko | Chief Medical Officer | Award | 350,000 | $N/A | $0 | |
| Nov 28, 2022 | Nagao Hideki | Executive | Sale | 6,754 | $2.25 | $15.2K | |
| Nov 22, 2022 | Nagao Hideki | Executive | Sale | 218 | $2.13 | $464 | |
| Nov 21, 2022 | Nagao Hideki | Executive | Sale | 5,365 | $2.18 | $11.7K | |
| Nov 17, 2022 | Nagao Hideki | Executive | Sale | 309 | $2.18 | $674 | |
| Aug 23, 2021 | Matsuda Kazuko | Executive | Option Exercise | 60,000 | $2.30 | $138.0K | |
| Jul 9, 2021 | Iwaki Yuichi | Executive | Option Exercise | 39,583 | $2.54 | $100.5K | |
| Jun 24, 2021 | Matsuda Kazuko | Executive | Option Exercise | 46,554 | $2.54 | $118.2K | |
| Jun 24, 2021 | Matsuda Kazuko | Executive | Option Exercise | 56,250 | $2.46 | $138.4K | |
| May 19, 2021 | Obrien Geoffrey | Executive | Option Exercise | 11,318 | $2.46 | $27.8K | |
| May 19, 2021 | Obrien Geoffrey | Executive | Option Exercise | 32,000 | $2.54 | $81.3K | |
| Mar 11, 2021 | Nagao Hideki | Executive | Sale | 2,354 | $7.40 | $17.4K | |
| Feb 25, 2021 | Iwaki Yuichi | Executive | Option Exercise | 86,250 | $2.46 | $212.2K | |
| Sep 15, 2020 | Nagao Hideki | Executive | Sale | 1,000 | $5.78 | $5.8K | |
| Aug 6, 2020 | Nagao Hideki | Executive | Option Exercise | 15,000 | $2.58 | $38.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 37 | $6.0M | 71.4% |
Purchase(P) | 43 | $1.4M | 16.4% |
Exercise (Options)(X) | 3 | $400.6K | 4.7% |
Disposition(D) | 1 | $367.8K | 4.4% |
Sale(S) | 10 | $256.2K | 3.0% |
Award(A) | 1 | $0 | 0.0% |
Insiders at MEDICINOVA INC are accumulating shares at an accelerated pace. With 14 insiders making 95 transactions totaling $1.4M in purchases versus $256.2K in sales, the net buying activity of $1.1M signals strong executive confidence. Masatsune Okajima (Executive) leads the buying activity with $4.1M in transactions across all time.